Clinical trial

Enzalutamide and Hormone Therapy Before, During, and After Radiation for High Risk Localized Prostate Cancer

NCT02064582

Study summary

ClinicalTrials.gov

Enzalutamide and Hormone Therapy Before, During, and After Radiation for High Risk Localized Prostate Cancer

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

3 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Mapped RxNorm record Enzalutamide Normalized identity: enzalutamide View linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Leuprolide acetate Normalized identity: leuprolide acetate View linked drug · Find medicine records · Find other trials using this name

RADIATION · Unmapped registry intervention radiation Find medicine records · Find other trials using this name

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2014-05-01

PhasePHASE2

Conditions

Prostate Cancerverified · MONDO: prostate cancer

Interventions

EnzalutamideDRUG · verified · RxNorm: enzalutamide

Leuprolide acetateDRUG · verified · RxNorm: leuprolide acetate

radiationRADIATION

Sponsors & collaborators

University of Texas Southwestern Medical Centerlead sponsor

Astellas Pharma US, Inc.collaborator

Mapped research locations

DallasTexas, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02064582 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.